Bioinformatic-based Identification of MicroRNAs with Biomarker Potential in Colon Cancer from Microarray Data

M. Valizadeh, E. Babaei, R. Sharifi, A. Yazdanbod
{"title":"Bioinformatic-based Identification of MicroRNAs with Biomarker Potential in Colon Cancer from Microarray Data","authors":"M. Valizadeh, E. Babaei, R. Sharifi, A. Yazdanbod","doi":"10.52547/JARUMS.20.2.212","DOIUrl":null,"url":null,"abstract":"Background & objectives: Colon cancer is a common disease in the world that causes high mortality in affected people. The lack of appropriate diagnostic and prognostic markers has led to the failure in early diagnosis of colorectal malignancies. MicroRNAs play an important role in controlling the expression of target genes involved in the development and progression of colon cancer. The aim of the present study was the bioinformatics identification of microRNAs with distinct expression in cancerous and non-cancerous colon samples. Methods: This type of study was theoretical bioinformatics and microarray data of 1513 colon cancer samples with the accession number of GSE115513 were obtained from the GEO site and marker genes were selected by using R program. Target genes of the identified microRNAs were provided by TARGETSCAN software and finally, the graphical network was plotted in Cytoscape software. Results: Analysis of microarray data showed that has-miR-663b, has-miR-650, has-miR-175p, has-miR-4539 and has-miR-501-3p have biomarker potential in cancer samples. Statistical analysis and investigation of the target genes indicated that miR-663b (ROC=0.8965, p=0.001) and has-miR-650 (ROC=0.9104, p=0.001) had significant distinct expression between cancerous and non-tumor margins with biomarker potential. Conclusion: The has-miR-663b and has-miR-650 genes can be used as diagnostic markers to distinguish colon cancer from non-cancerous samples.","PeriodicalId":30758,"journal":{"name":"Journal of Ardabil University of Medical Sciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ardabil University of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/JARUMS.20.2.212","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background & objectives: Colon cancer is a common disease in the world that causes high mortality in affected people. The lack of appropriate diagnostic and prognostic markers has led to the failure in early diagnosis of colorectal malignancies. MicroRNAs play an important role in controlling the expression of target genes involved in the development and progression of colon cancer. The aim of the present study was the bioinformatics identification of microRNAs with distinct expression in cancerous and non-cancerous colon samples. Methods: This type of study was theoretical bioinformatics and microarray data of 1513 colon cancer samples with the accession number of GSE115513 were obtained from the GEO site and marker genes were selected by using R program. Target genes of the identified microRNAs were provided by TARGETSCAN software and finally, the graphical network was plotted in Cytoscape software. Results: Analysis of microarray data showed that has-miR-663b, has-miR-650, has-miR-175p, has-miR-4539 and has-miR-501-3p have biomarker potential in cancer samples. Statistical analysis and investigation of the target genes indicated that miR-663b (ROC=0.8965, p=0.001) and has-miR-650 (ROC=0.9104, p=0.001) had significant distinct expression between cancerous and non-tumor margins with biomarker potential. Conclusion: The has-miR-663b and has-miR-650 genes can be used as diagnostic markers to distinguish colon cancer from non-cancerous samples.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于生物信息学的微阵列数据识别结肠癌中具有生物标志物潜力的microrna
背景与目的:癌症是世界上一种常见的疾病,它会导致受影响人群的高死亡率。缺乏合适的诊断和预后标志物导致结直肠恶性肿瘤的早期诊断失败。微小RNA在控制参与癌症发展和进展的靶基因表达方面发挥着重要作用。本研究的目的是对癌性和非癌性结肠样本中具有不同表达的微小RNA进行生物信息学鉴定。方法:采用理论生物信息学方法,从GEO位点获得1513份登录号为GSE115513的癌症样品的微阵列数据,用R程序筛选标记基因。已鉴定的微小RNA的靶基因由TARGETSCAN软件提供,最后在Cytoscape软件中绘制图形网络。结果:微阵列数据分析表明,has-miR663b、has-miR-650、has-miR-175p、has-miR-4539和has-miR-501-3p在癌症样品中具有生物标志物潜力。对靶基因的统计分析和研究表明,miR-663b(ROC=0.8965,p=0.001)和has-miR-650(ROC=0.9104,p=0.001。结论:has-miR-663b和has-miR-650基因可作为结肠癌与非结肠癌的诊断标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
6 weeks
期刊最新文献
A case of Thrombotic Thrombocytopenic Purpura following the AstraZeneca Vaccine Evaluation and Comparison of the Changes of Blood Biochemical and Hematological Factors in Adults with and Without History of COVID-19 Fabrication and Characterization of Betamethasone-loaded Oral Thin Films as a Novel Drug Delivery Platform for Oral Lichen Planus and Recurrent Mouth Ulcers Investigating Fenugreek Seed Aqueous Extract on Sperm Parameters in Selected Type II Rats Prediction of Coronary Heart Disease Using Discriminant Analysis Algorithm in Active Elderly Men
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1